Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles:: A nuclear magnetic resonance and electron spin resonance study

被引:137
作者
Jores, K
Mehnert, W
Mäder, K
机构
[1] Univ Halle Wittenberg, Inst Pharmaceut Technol & Biopharm, D-06120 Halle An Der Saale, Germany
[2] Free Univ Berlin, Inst Pharm, Dept Pharmaceut Technol, D-12169 Berlin, Germany
关键词
solid lipid nanoparticles; colloidal carrier; nanoemulsion; ESR; NMR; SLN; NLC;
D O I
10.1023/A:1025065418309
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Recently, colloidal dispersions made of mixtures from solid and liquid lipids have been described to combine controlled-release characteristics with higher drug-loading capacities than solid lipid nanoparticles (SLNs). It has been proposed that these nanostructured lipid carriers (NLCs) are composed of oily droplets that are embedded in a solid lipid matrix. The present work investigates the structure and performance of NLCs. Methods. Colloidal lipid dispersions were produced by high-pressure homogenization and characterized by laser diffraction, photon correlation spectroscopy, wide-angle x-ray scattering, and differential scanning calorimetry. Proton nuclear magnetic resonance spectroscopy and electron spin resonance experiments were performed to investigate the mobility of the components and the molecular environment of model drugs. Furthermore, a nitroxide reduction assay with ascorbic acid was conducted to explore the accessibility of the lipid model drug from the outer aqueous phase. Results. Proton nuclear magnetic resonance spectra clearly demonstrate that NLC nanoparticles differ from nanoemulsions and from SLNs by forming a liquid compartment that is in strong interaction to the solid lipid. The electron spin resonance model drug was found to be accommodated either on the particle surface with close water contact (SLN) or additionally in the oil (NLC). The oil compartment must be localized on the particle surface, because it can be easily reached by ascorbic acid. Conclusion. Neither SLN nor NLC lipid nanoparticles showed any advantage with respect to incorporation rate or retarded accessibility to the drug compared with conventional nanoemulsions. The experimental data let us conclude that NLCs are not spherical solid lipid particles with embedded liquid droplets, but they are rather solid platelets with oil present between the solid platelet and the surfactant layer.
引用
收藏
页码:1274 / 1283
页数:10
相关论文
共 32 条
[1]   POLY(ETHYLENE OXIDE)-POLY(PROPYLENE OXIDE)-POLY(ETHYLENE OXIDE) BLOCK-COPOLYMER SURFACTANTS IN AQUEOUS-SOLUTIONS AND AT INTERFACES - THERMODYNAMICS, STRUCTURE, DYNAMICS, AND MODELING [J].
ALEXANDRIDIS, P ;
HATTON, TA .
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 1995, 96 (1-2) :1-46
[2]  
*BASF, 1997, TECHN INF LUTR F 68
[3]  
BOCKISCH M, 1993, NAHRUNGSFETTE OLE
[4]   Crystallization tendency and polymorphic transitions in triglyceride nanoparticles [J].
Bunjes, H ;
Westesen, K ;
Koch, MHJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 129 (1-2) :159-173
[5]   Incorporation of the model drug ubidecarenone into solid lipid nanoparticles [J].
Bunjes, H ;
Drechsler, M ;
Koch, MHJ ;
Westesen, K .
PHARMACEUTICAL RESEARCH, 2001, 18 (03) :287-293
[6]   Effect of particle size on colloidal solid triglycerides [J].
Bunjes, H ;
Koch, MHJ ;
Westesen, K .
LANGMUIR, 2000, 16 (12) :5234-5241
[7]  
BUNJES H, 1998, SUBMICRON EMULSIONS, P175
[8]  
FISCHERCARIUS A, 1998, THESIS FREE U BERLIN
[9]  
Haberland A, 2003, ALTEX-ALTERN TIEREXP, V20, P3
[10]  
Hagemann JW, 1988, CRYSTALLIZATION POLY